{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:52:39Z","timestamp":1782690759660,"version":"3.54.5"},"reference-count":80,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. Department of Veterans Affairs","award":["CSR&D 1I01CX001686-01"],"award-info":[{"award-number":["CSR&D 1I01CX001686-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic liver diseases, fibrosis, cirrhosis, and HCC are often a consequence of persistent inflammation. However, the transition mechanisms from a normal liver to fibrosis, then cirrhosis, and further to HCC are not well understood. This study focused on the role of the tumor stem cell protein doublecortin-like kinase 1 (DCLK1) in the modulation of molecular factors in fibrosis, cirrhosis, or HCC. Serum samples from patients with hepatic fibrosis, cirrhosis, and HCC were analyzed via ELISA or NextGen sequencing and were compared with control samples. Differentially expressed (DE) microRNAs (miRNA) identified from these patient sera were correlated with DCLK1 expression. We observed elevated serum DCLK1 levels in fibrosis, cirrhosis, and HCC patients; however, TGF-\u03b2 levels were only elevated in fibrosis and cirrhosis. While DE miRNAs were identified for all three disease states, miR-12136 was elevated in fibrosis but was significantly increased further in cirrhosis. Additionally, miR-1246 and miR-184 were upregulated when DCLK1 was high, while miR-206 was downregulated. This work distinguishes DCLK1 and miRNAs\u2019 potential role in different axes promoting inflammation to tumor progression and may serve to identify biomarkers for tracking the progression from pre-neoplastic states to HCC in chronic liver disease patients as well as provide targets for treatment.<\/jats:p>","DOI":"10.3390\/ijms25126481","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:52:53Z","timestamp":1718337173000},"page":"6481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0594-7960","authenticated-orcid":false,"given":"Landon L.","family":"Moore","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-3852","authenticated-orcid":false,"given":"Dongfeng","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripathi","family":"Sureban","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-7456","authenticated-orcid":false,"given":"Kamille","family":"Pitts","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3158-1705","authenticated-orcid":false,"given":"Nasya","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Natural Sciences, Langston University, Langston, OK 73050, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Fazili","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Harty","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Oseini","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-437X","authenticated-orcid":false,"given":"Kai","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-0872","authenticated-orcid":false,"given":"Michael","family":"Bronze","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2487-5242","authenticated-orcid":false,"given":"Courtney W.","family":"Houchen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1186\/1755-1536-5-S1-S27","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1245\/s10434-022-12390-7","article-title":"Variation of Hepatocellular Carcinoma Treatment Patterns and Survival Across Geographic Regions in a Veteran Population","volume":"29","author":"Ju","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Force, M., Park, G., Chalikonda, D., Roth, C., Cohen, M., Halegoua-DeMarzio, D., and Hann, H.W. (2022). Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level. Viruses, 14.","DOI":"10.3390\/v14040775"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41598-021-03710-0","article-title":"Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown","volume":"12","author":"Desquilles","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Feng, H., Wei, X., Pang, L., Wu, Y., Hu, B., Ruan, Y., Liu, Z., Liu, J., and Wang, T. (2020). Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00189"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/hep.23595","article-title":"Themes of liver transplantation","volume":"51","author":"Starzl","year":"2010","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Schueller, F., Roy, S., Vucur, M., Trautwein, C., Luedde, T., and Roderburg, C. (2018). The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010261"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-020-0169-z","article-title":"Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-\u03b2 pathway","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Messner, C.J., Schmidt, S., \u00d6zkul, D., Gaiser, C., Terracciano, L., Kr\u00e4henb\u00fchl, S., and Suter-Dick, L. (2021). Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189799"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Huang, Y.H., Yang, Y.L., and Wang, F.S. (2018). The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201806.0161.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ncrna.2022.01.004","article-title":"Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis","volume":"7","author":"Gumilas","year":"2022","journal-title":"Non-Coding RNA Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"03000605231197058","DOI":"10.1177\/03000605231197058","article-title":"Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A comprehensive review","volume":"51","author":"Mubeen","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chhetri, D., Vengadassalapathy, S., Venkadassalapathy, S., Balachandran, V., Umapathy, V.R., Veeraraghavan, V.P., Jayaraman, S., Patil, S., Iyaswamy, A., and Palaniyandi, K. (2022). Pleiotropic effects of DCLK1 in cancer and cancer stem cells. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.965730"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sureban, S.M., May, R., Mondalek, F.G., Qu, D., Ponnurangam, S., Pantazis, P., Anant, S., Ramanujam, R.P., and Houchen, C.W. (2011). Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J. Nanobiotechnol., 9.","DOI":"10.1186\/1477-3155-9-40"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/0008-5472.CAN-10-2738","article-title":"DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism","volume":"71","author":"Sureban","year":"2011","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.18632\/oncotarget.2393","article-title":"DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition","volume":"5","author":"Chandrakesan","year":"2014","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41416-020-0823-9","article-title":"Cancer stemness in hepatocellular carcinoma: Mechanisms and translational potential","volume":"122","author":"Tsui","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1038\/s41598-020-67401-y","article-title":"Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical \u03b2-catenin-dependent mechanism","volume":"10","author":"Ali","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","unstructured":"The Cancer Genome Atlas Research Network (Lead Contact David A. Wheeler) (2017). Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 169, 1327\u20131341.e1323."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e17198","DOI":"10.15252\/emmm.202217198","article-title":"Macrophage DCLK1 promotes atherosclerosis via binding to IKKbeta and inducing inflammatory responses","volume":"15","author":"Huang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e0119423","DOI":"10.1128\/jvi.01194-23","article-title":"Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network","volume":"97","author":"Undi","year":"2023","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-023-01642-3","article-title":"Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6\/STAT3 signaling","volume":"25","author":"Liu","year":"2023","journal-title":"Breast Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1128\/JVI.05920-11","article-title":"Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts","volume":"85","author":"Ali","year":"2011","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"20327","DOI":"10.18632\/oncotarget.3972","article-title":"Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases","volume":"6","author":"Ali","year":"2015","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37200","DOI":"10.18632\/oncotarget.5808","article-title":"Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism","volume":"6","author":"Sureban","year":"2015","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1038\/s41598-023-29074-1","article-title":"Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions","volume":"13","author":"Karere","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_31","first-page":"257","article-title":"Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells","volume":"7","author":"Chandrakesan","year":"2016","journal-title":"J. Carcinog. Mutagen."},{"key":"ref_32","first-page":"2923","article-title":"Modulation of TGF-beta signaling during progression of chronic liver diseases","volume":"14","author":"Matsuzaki","year":"2009","journal-title":"FBL"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao","year":"2019","journal-title":"Cancer Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"FSO693","DOI":"10.2144\/fsoa-2021-0014","article-title":"The role and underlying mechanism of miR-1299 in cancer","volume":"7","author":"Kaiyuan","year":"2021","journal-title":"Future Sci. OA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2292481","DOI":"10.1155\/2022\/2292481","article-title":"DNAJA1 Stabilizes EF1A1 to Promote Cell Proliferation and Metastasis of Liver Cancer Mediated by miR-205-5p","volume":"2022","author":"Yi","year":"2022","journal-title":"J. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12935-022-02833-2","article-title":"Emerging roles and mechanisms of miR-206 in human disorders: A comprehensive review","volume":"22","author":"Khalilian","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3748\/wjg.v26.i11.1113","article-title":"Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis","volume":"26","author":"Iacob","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Morishita, A., Oura, K., Tadokoro, T., Fujita, K., Tani, J., and Masaki, T. (2021). MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers, 13.","DOI":"10.3390\/cancers13030514"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"601710","DOI":"10.3389\/fonc.2020.601710","article-title":"Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease","volume":"10","author":"Suresh","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000343852","article-title":"From cirrhosis to hepatocellular carcinoma: New molecular insights on inflammation and cellular senescence","volume":"2","author":"Ramakrishna","year":"2013","journal-title":"Liver Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5493\/wjem.v6.i1.21","article-title":"Hepatocellular carcinoma: Where are we?","volume":"6","author":"Mazzanti","year":"2016","journal-title":"World J. Exp. Med."},{"key":"ref_44","first-page":"314","article-title":"Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma","volume":"48","author":"Edoo","year":"2019","journal-title":"Iran. J. Public Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4149\/neo_2013_018","article-title":"Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma","volume":"60","author":"Qi","year":"2013","journal-title":"Neoplasma"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jceh.2013.02.246","article-title":"Elevated alpha fetoprotein, no hepatocellular carcinoma","volume":"3","author":"Patil","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fares, S., Wehrle, C.J., Hong, H., Sun, K., Jiao, C., Zhang, M., Gross, A., Allkushi, E., Uysal, M., and Kamath, S. (2024). Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma. Cancers, 16.","DOI":"10.3390\/cancers16081453"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Qu, D., Johnson, J., Chandrakesan, P., Weygant, N., May, R., Aiello, N., Rhim, A., Zhao, L., Zheng, W., and Lightfoot, S. (2015). Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118933"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6402925","DOI":"10.1155\/2019\/6402925","article-title":"Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer","volume":"2019","author":"Qu","year":"2019","journal-title":"J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sureban, S.M., Berahovich, R., Zhou, H., Xu, S., Wu, L., Ding, K., May, R., Qu, D., Bannerman-Menson, E., and Golubovskaya, V. (2019). DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers. Cancers, 12.","DOI":"10.3390\/cancers12010054"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.18632\/oncotarget.3059","article-title":"DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma","volume":"6","author":"Weygant","year":"2015","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10620-014-3347-4","article-title":"DCLK1 is detectable in plasma of patients with Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"60","author":"Whorton","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.7150\/thno.72037","article-title":"DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5\/COX2 axis","volume":"12","author":"Kim","year":"2022","journal-title":"Theranostics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2016.03.033","article-title":"TGF-\u03b2 signaling in liver and gastrointestinal cancers","volume":"379","author":"Katz","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Damaskos, C., Garmpis, N., Dimitroulis, D., Garmpi, A., Psilopatis, I., Sarantis, P., Koustas, E., Kanavidis, P., Prevezanos, D., and Kouraklis, G. (2022). Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead\u2014A Systematic Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214117"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.3748\/wjg.v23.i48.8439","article-title":"Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis","volume":"23","author":"Miranda","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_57","first-page":"24","article-title":"The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis","volume":"4","author":"Roy","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Roberts, T.C., Coenen-Stass, A.M., Betts, C.A., and Wood, M.J. (2014). Detection and quantification of extracellular microRNAs in murine biofluids. Biol. Proced. Online, 16.","DOI":"10.1186\/1480-9222-16-5"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","article-title":"Secretory mechanisms and intercellular transfer of microRNAs in living cells","volume":"285","author":"Kosaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1038\/emm.2013.81","article-title":"U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis","volume":"45","author":"Benz","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Roderburg, C., Mollnow, T., Bongaerts, B., Elfimova, N., Vargas Cardenas, D., Berger, K., Zimmermann, H., Koch, A., Vucur, M., and Luedde, M. (2012). Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032999"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.27369","article-title":"Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients","volume":"61","author":"Anadol","year":"2015","journal-title":"Hepatology"},{"key":"ref_64","first-page":"1172","article-title":"Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases","volume":"35","author":"Roderburg","year":"2014","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41419-020-02832-z","article-title":"miR-16 integrates signal pathways in myofibroblasts: Determinant of cell fate necessary for fibrosis resolution","volume":"11","author":"Pan","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_66","first-page":"137","article-title":"Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma","volume":"23","author":"Cheng","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Khoshbakht","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_68","first-page":"1431","article-title":"Effect of miR-12136 on Drug Sensitivity of Drug-Resistant Cell Line Michigan Cancer Foundation-7\/Doxorubicin by Regulating ATP Binding Cassette Subfamily B Member 1","volume":"10","author":"Yuan","year":"2020","journal-title":"J. Biomater. Tissue Eng."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard, S., Khoshbakht, T., Hussen, B.M., Taheri, M., and Samadian, M. (2022). A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.771835"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"43897","DOI":"10.18632\/oncotarget.14915","article-title":"miRNA-1246 induces pro-inflammatory responses in mesenchymal stem\/stromal cells by regulating PKA and PP2A","volume":"8","author":"Bott","year":"2017","journal-title":"Oncotarget"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/sci.2017.01.01","article-title":"microRNA regulation of human pancreatic cancer stem cells","volume":"4","author":"Xu","year":"2017","journal-title":"Stem Cell Investig."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zhao, H., and Tian, H. (2024). Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-kappaB and MAPK pathways. J. Biochem. Mol. Toxicol., 38.","DOI":"10.1002\/jbt.23566"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-015-0142-9","article-title":"MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma","volume":"34","author":"Cheng","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1080\/15384101.2022.2057633","article-title":"Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184","volume":"21","author":"Guo","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13402-020-00564-y","article-title":"Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion","volume":"44","author":"Li","year":"2021","journal-title":"Cell. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biopha.2013.09.005","article-title":"miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC)","volume":"68","author":"Gao","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: Evaluation of the patient for liver transplantation","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Law, C.W., Chen, Y., Shi, W., and Smyth, G.K. (2014). voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol., 15.","DOI":"10.1186\/gb-2014-15-2-r29"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:28Z","timestamp":1760108248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":80,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25126481"],"URL":"https:\/\/doi.org\/10.3390\/ijms25126481","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}